Toplast Cool And Hot Menthol 4percent Plus Capsaicin 0.025percent
NDC Package 73279-0010-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Toplast Cool And Hot Menthol 4percent Plus Capsaicin 0.025percent is a . Marketed by Icure Pharmaceutical Inc, Wanju Factory, this product is identified by NDC 73279-0010 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
73279-0010-2
Package Description
10 POUCH in 1 CARTON / 5 PATCH in 1 POUCH (73279-0010-1)
Product Code
73279-0010
11-Digit Billing Format
73279001002

Clinical Specifications

Proprietary Name
Toplast Cool And Hot Menthol 4percent Plus Capsaicin 0.025percent
Dosage Form
-

Regulatory & Marketing

Labeler Name
Icure Pharmaceutical Inc, Wanju Factory
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
07-01-2020
End Marketing Date
07-25-2020
Listing Expiration
07-25-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73279-0010-2 identifies a specific commercial package of 10 pouch in 1 carton / 5 patch in 1 pouch (73279-0010-1) of Toplast Cool And Hot Menthol 4percent Plus Capsaicin 0.025percent, labeled by Icure Pharmaceutical Inc, Wanju Factory. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Icure Pharmaceutical Inc, Wanju Factory on July 01, 2020. The current certification is valid through July 25, 2020.

How is this Icure Pharmaceutical Inc, Wanju Factory product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73279001002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
73279-0010-2
11-Digit CMS (5-4-2)
73279-0010-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.